The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features (Q43225312)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 December 2009

Language	Label	Description	Also known as
English	The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features	scientific article published on 7 December 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

amyotrophic lateral sclerosis

0 references

Carolina Di Somma

9

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Annamaria Colao

10

object named as

A Colao

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

author name string

M T Pellecchia

1

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

R Pivonello

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

M R Monsurrò

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

F Trojsi

4

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

K Longo

5

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

G Piccirillo

6

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

C Pivonello

7

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

M Rocco

8

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

G Tedeschi

11

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

P Barone

12

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

publication date

7 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

European Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

666-671

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Circulating insulin-like growth factor I and functional recovery from spinal cord injury under enriched housing conditions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Recombinant growth hormone treatment of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Growth hormone secretion is impaired in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Insulin-like growth factors cross the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Role of insulin-like growth factor I signaling in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Role of IGF-I in skeletal muscle mass maintenance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

The insulin-like growth factor system and its pleiotropic functions in brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02896.X

21 January 2018

Identifiers

10.1111/J.1468-1331.2009.02896.X

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43225312&oldid=1984172494"